EU/3/15/1521
Table of contents
About
On 28 July 2015, orphan designation (EU/3/15/1521) was granted by the European Commission to Dr Ulrich Granzer, Germany, for artesunate for the treatment of malaria.
The sponsorship was transferred to B And O Pharm, France, in June 2020.
Key facts
Active substance |
Artesunate
|
Disease / condition |
Treatment of malaria
|
Date of first decision |
28/07/2015
|
Outcome |
Positive
|
EU designation number |
EU/3/15/1521
|
Review of designation
The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.
Sponsor's contact details
B And O Pharm
Zac De La Masquere
500 Rue De L Hers
31750 Escalquens
France
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.